Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Senti Biosciences, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
Revenues4.32.80.6
            Revenue growth55.2%387.8% 
Cost of goods sold0.00.00.0
Gross profit4.32.80.6
            Gross margin100.0%100.0%100.0%
Research and development34.122.016.0
General and administrative40.821.39.3
EBIT-70.6-40.5-24.9
            EBIT margin-1647.9%-1465.7%-4404.9%
Pre-tax income-58.2-55.3-19.9
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income-58.2-55.3-19.9
            Net margin-1358.1%-2003.6%-3509.2%
 
Diluted EPS($2.23)($19.00)($1.43)
Shares outstanding (diluted)26.12.913.9
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy